The Effect of Open-Label Semaglutide on Metabolic Dysfunction–Associated Steatotic Liver Disease in People With HIV
Annals of Internal Medicine · 2024-06 · 177 (6) · 835-838
DOI: 10.7326/m23-3354 ↗Kurz gefasst
Leserbrief in der Zeitschrift Annals of Internal Medicine, 2024-06. Verfasst von Jordan E Lake und 14 weiteren Autor:innen. Beteiligte Einrichtung: UTHealth Houston, Houston, Texas. Hauptthemen laut MEDLINE: HIV Infections, Glucagon-Like Peptides, Fatty Liver. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- UTHealth Houston, Houston, Texas.
- Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
- School of Engineering Medicine, Texas A&M University, Houston, Texas, and ForeSpect PLLC, Pearland, Texas.
- Weill Cornell College of Medicine, New York, New York.
- Social & Scientific Systems, Inc., and FHI 360, Durham, North Carolina.
- National Institute of Allergy and Infectious Diseases, Rockville, Maryland.
ORCID-Profile: Karin L Klingman, Pablo F Belaunzaran-Zamudio, Carl J Fichtenbaum, Hugo Perazzo, Todd T Brown, Kristine M Erlandson
Förderung
- NIAID NIH HHS
- NIDDK NIH HHS
- NCATS NIH HHS
Zitieren
APA
Lake, J. E., Kitch, D. W., Kantor, A., Muthupillai, R., Klingman, K. L., Vernon, C., Belaunzaran-Zamudio, P. F., Fichtenbaum, C. J., Heath, S., Perazzo, H., Corey, K., Brown, T. T., Landay, A., Sattler, F., & Erlandson, K. M. (2024). The Effect of Open-Label Semaglutide on Metabolic Dysfunction–Associated Steatotic Liver Disease in People With HIV. Annals of Internal Medicine, 177(6), 835-838. https://doi.org/10.7326/m23-3354
Vancouver
Lake JE, Kitch DW, Kantor A, Muthupillai R, Klingman KL, Vernon C, et al. The Effect of Open-Label Semaglutide on Metabolic Dysfunction–Associated Steatotic Liver Disease in People With HIV. Annals of Internal Medicine. 2024;177(6):835-838. doi:10.7326/m23-3354
BibTeX
@article{Lake2024,
author = {Lake, Jordan E and Kitch, Douglas W and Kantor, Amy and Muthupillai, Raja and Klingman, Karin L and Vernon, Christina and Belaunzaran-Zamudio, Pablo F and Fichtenbaum, Carl J and Heath, Sonya and Perazzo, Hugo and Corey, Kathleen and Brown, Todd T and Landay, Alan and Sattler, Fred and Erlandson, Kristine M},
title = {The Effect of Open-Label Semaglutide on Metabolic Dysfunction–Associated Steatotic Liver Disease in People With HIV},
journal = {Annals of Internal Medicine},
year = {2024},
volume = {177},
number = {6},
pages = {835--838},
doi = {10.7326/m23-3354}
}
EUVIMED